Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial
Innovation (Camb). 2025 Jul 5;6(8):101015. doi: 10.1016/j.xinn.2025.101015. eCollection 2025 Aug 4. ABSTRACT This phase 3 trial evaluated the efficacy and […]
